ME

Global Health LtdNSE MEDANTA Stock Report

Last reporting period 30 Sep, 2023

Updated 18 Sep, 2024

Last price

Market cap $B

1.325

Small

Exchange

XNSE - National Stock Exchange Of India

MEDANTA.NS Stock Analysis

ME

Uncovered

Global Health Ltd is uncovered by Eyestock quantitative analysis.

Market cap $B

1.325

Dividend yield

Shares outstanding

268.51 B

Global Health Ltd. engages in the provision of healthcare, pathology, and other medical services. The company is headquartered in New Delhi, Delhi and currently employs 9,350 full-time employees. The company went IPO on 2022-11-16. Medanta delivers advanced, end-to-end healthcare in Delhi, Gurugram, Indore, Ranchi, Patna, and Lucknow through its network of five hospitals, six Mediclinic, diagnostic laboratories, homecare, and telemedicine services. The company provides treatments for coronary artery disease, head and neck cancer, acute myeloid leukemia, epilepsy, hip fracture, Parkinson's disease, refractive error, prostate cancer, chronic kidney disease, cerebral stroke, sepsis, liver cirrhosis, rheumatoid, arthritis, hypertension, diabetes, bronchial asthma, stomach cancer, and chronic otitis media. Medanta specializes in cardiac surgery, nephrology, urology, andrology, dermatology, ophthalmology, radiology and imaging, dental sciences, and interventional cardiology, among others. Its facilities and services include medicine delivery, lab tests & diagnostics, book homecare services and others.

View Section: Eyestock Rating